63. 特発性血小板減少性紫斑病 Idiopathic thrombocytopenic purpura Clinical trials / Disease details


臨床試験数 : 363 薬物数 : 217 - (DrugBank : 43) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 137

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05232149
(ClinicalTrials.gov)
February 202220/12/2021A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune ThrombocytopeniaA Randomized, Multi-center, Adaptive Phase IIa/IIb Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Persistent or Chronic Primary Immune ThrombocytopeniaPrimary Immune ThrombocytopeniaDrug: Orelabrutinib( lower dose);Drug: Orelabrutinib( higher dose)Beijing InnoCare Pharma Tech Co., Ltd.NULLNot yet recruiting18 Years80 YearsAll30Phase 2China
2NCT05020288
(ClinicalTrials.gov)
September 1, 202112/8/2021A Clinical Trial of the Orelabrutinib in the Management of Refractory ITPA Prospective, Open-label, Multicenter,Single-armed Study of Orelabrutinib in the Treatment of Refractory Primary Immune Thrombocytopenia (ITP)Immune Thrombocytopenia;Bruton's Tyrosine KinaseDrug: OrelabrutinibShandong UniversityNULLNot yet recruiting18 Years70 YearsAll40Phase 2NULL